0001214659-24-011218.txt : 20240621
0001214659-24-011218.hdr.sgml : 20240621
20240621135044
ACCESSION NUMBER: 0001214659-24-011218
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240620
FILED AS OF DATE: 20240621
DATE AS OF CHANGE: 20240621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Krop Julie
CENTRAL INDEX KEY: 0001643127
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38599
FILM NUMBER: 241059530
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc.
CENTRAL INDEX KEY: 0001398733
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 208623253
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
BUSINESS PHONE: 908-941-1900
MAIL ADDRESS:
STREET 1: 30 TECHNOLOGY DRIVE
CITY: WARREN
STATE: NJ
ZIP: 07059
FORMER COMPANY:
FORMER CONFORMED NAME: MonoSol Rx, Inc.
DATE OF NAME CHANGE: 20070507
4
1
marketforms-66326.xml
PRIMARY DOCUMENT
X0508
4
2024-06-20
0001398733
Aquestive Therapeutics, Inc.
AQST
0001643127
Krop Julie
C/O AQUESTIVE THERAPEUTICS, INC.
30 TECHNOLOGY DRIVE
WARREN
NJ
07059
true
false
false
false
0
Stock Option (Right to Purchase)
2.50
2024-06-20
4
A
false
38000
0
A
2025-06-20
2034-06-20
Common Stock
38000
38000
D
The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date.
/s/ Lori Braender, as Attorney-In-Fact
2024-06-24